REQUEST A DEMO
Total
USD $0.00
Search more companies

Cee Pharma & Distribution, A.S. (Czech Republic)

Main Activities: Real Estate
Full name: Cee Pharma & Distribution, A.S. Profile Updated: November 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Cee Pharma & Distribution, A.S. is based in Czech Republic. The head office is in Prague. It operates in the Real Estate industry. The company was established on June 23, 2016. There are currently 10 - 19 (2024) people employed by Cee Pharma & Distribution, A.S.. The company’s latest financial report indicates a net sales revenue increase of 20.16% in 2023. Its’ total assets recorded a negative growth of 35.36%. The enterprise’s net profit margin decreased by 1.95% in 2023.

Headquarters
namesti 14. rijna 1307/2
Prague; The City of Prague; Postal Code: 15000

Contact Details: Purchase the Cee Pharma & Distribution, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cee Pharma & Distribution, A.S. report to view the information.
Outstanding Shares:
Purchase the Cee Pharma & Distribution, A.S. report to view the information.
Registered Capital:
Purchase the Cee Pharma & Distribution, A.S. report to view the information.
Incorporation Date:
June 23, 2016
Key Executives
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Cee Pharma & Distribution, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
20.16%
Total operating revenue
20.16%
Operating profit (EBIT)
-9.5%
EBITDA
-4.96%
Net Profit (Loss) for the Period
-5.19%
Total assets
-35.36%
Total equity
15.71%
Operating Profit Margin (ROS)
-2.25%
Net Profit Margin
-1.95%
Return on Equity (ROE)
-2.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?